Protein Buddy

Protein after you stop a GLP-1

In the STEP 1 extension people regained two thirds of the weight within a year of stopping. What that means for protein, and what the trial did not measure.

2 min read
A weight curve dipping and rebounding above a steady gold bar

What happens to protein and muscle when you stop a GLP-1 medication?

In the STEP 1 trial extension participants regained about two thirds of the weight they had lost within a year of stopping semaglutide. That trial measured weight, not body composition, so what comes back as muscle and what comes back as fat is not settled. Protein intake and resistance training remain the levers you control.

Key takeaways

  • In the STEP 1 trial extension, participants who had lost 17.3 percent of body weight on semaglutide regained 11.6 percentage points of it in the year after stopping, ending at a net 5.6 percent below where they started.
  • That extension reported body weight, BMI and cardiometabolic measures. It did not report lean mass or fat mass, so it cannot tell you what the regained weight was made of.
  • Weight lost on a GLP-1 includes lean tissue. In the SURMOUNT-1 body composition analysis roughly three quarters of the loss was fat and roughly one quarter was lean mass.
  • The protein recommendations do not change when you stop. They are set per kilogram of body weight and by age, so the target moves only as your weight does.
  • Appetite returns, which makes hitting a protein target easier rather than harder. The habit is the part worth keeping through the transition.

People stop these medications for all sorts of reasons: cost, side effects, supply, or because they reached the weight they were aiming for. The question that follows is the same in every case, and there is one trial that answers a large part of it.

What the trial extension found

STEP 1 was the semaglutide trial that produced the headline figure of 17.3 percent body weight lost over 68 weeks. Its extension followed a subset of those participants for a further year, with no drug and no lifestyle programme.

By week 120, that group had regained 11.6 percentage points of the weight they had lost. They finished around 5.6 percent below where they started, having been 17.3 percent below at the end of treatment.1

11.6 of 17.31

Percentage points of body weight regained in the year after the drug stopped, out of the 17.3 lost on it

Two things are true in that sentence at once, and it is worth holding both. Most of the loss came back. Some of it did not.

Why body composition is the open question

The extension reported body weight, BMI, blood pressure, HbA1c, CRP and lipids. It did not report lean mass or fat mass.1

That matters more than it sounds, because the interesting question about regain is not how many kilograms returned but what they were made of. Weight lost on these drugs is not all fat: in the SURMOUNT-1 body composition analysis, roughly three quarters of the loss was fat mass and roughly one quarter was lean mass.2 Whether regained weight comes back in the same proportion, or skews toward fat, is not something this trial can tell you.

Anyone who states it confidently in either direction is going beyond the evidence. The useful response to an open question is not to guess at it, it is to act on the parts that are not open.

What to keep doing after the last dose

The protein recommendations do not have a special case for stopping a medication. They are set per kilogram of body weight, and they rise with age: at least 1.0 to 1.2 g/kg a day from around 65, higher during illness.3 The ESPEN group makes the same recommendation and pairs it with resistance exercise rather than offering it alone.4

So the target does not change. Three practical things do:

  • Recalculate the number. It is per kilogram, so if your weight has moved a lot the grams figure has moved with it.
  • Expect appetite back. This is the part people are unprepared for. Hitting a protein target gets easier, and so does drifting past everything else.
  • Keep the training. Protein supplies the material and loading the muscle supplies the signal. Neither substitutes for the other, which is the one point the expert groups repeat most.

Important

GLP-1 receptor agonists are prescription medications and stopping one is a decision that belongs with the clinician who prescribed it, including the question of tapering. This article is general reference material about protein, not medical advice, and it does not replace their guidance.

If you are still on the medication, protein and muscle loss on GLP-1 medications covers the losing phase in more detail.

More questions about GLP-1

Do you regain weight after stopping Ozempic?

Most people in the trial did. In the STEP 1 extension, participants regained 11.6 of the 17.3 percentage points of body weight they had lost, measured one year after the last dose. They were still below their starting weight on average, by about 5.6 percent, but the majority of the loss had returned.

Do you lose muscle when you stop a GLP-1?

Stopping does not itself cause muscle loss. The muscle question belongs to the losing phase, where roughly a quarter of the weight lost was lean mass in the SURMOUNT-1 analysis. What happens to body composition during regain was not measured in the STEP 1 extension, so it is genuinely an open question rather than one with a hidden answer.

How much protein should I eat after coming off a GLP-1?

The same per-kilogram figure that applied while you were on it. That is 0.8 g/kg a day as a floor, 1.0 to 1.2 g/kg from around age 65, and higher again if you are still losing weight or training. Your absolute number in grams moves with your weight, so it is worth recalculating.

Should I keep tracking protein after I stop?

It is the cheapest habit to keep. Appetite returning makes total intake easier, which is exactly when a specific target stops being urgent and starts being easy to drift away from. One number a day takes seconds and tells you whether the protein came back along with the appetite.

References
History of updates
Last checked First published Every article is re-read against its sources when we touch it. What that check covers is set out in our editorial standards.